The Union Health Ministry has issued a draft notification proposing a ban on the manufacture, import, sale, and distribution of 34 antimicrobials
The National Accreditation Board for Testing and Calibration Laboratories (NABL) is encouraging its accredited Conformity Assessment Bodies
Bayer has initiated a Phase I clinical trial for BAY 3670549, a first-in-class, highly selective G-protein-coupled inwardly rectifying potassium channel 4 (GIRK4) inhibitor, targeting atrial fibrillation (AFib)...
Bharat Biotech International Ltd announced that it successfully completed Phase III clinical trials for its oral cholera vaccine, Hillchol. The double-blind, randomized study evaluated Hillchol for safety, immunogenicity, and consistency, and...
Tata 1mg has partnered with Unicommerce, a leading e-commerce enablement SaaS platform in India, to boost its order processing and logistics capabilities. Through this collaboration, Tata 1mg aims to automate and streamline its backend operations...
The Subject Expert Committee (SEC), which advises India’s central drug regulatory authority on new drugs and clinical trials, has recommended that Biological E's COVID-19 vaccine
Roche has announced FDA approval for the Ventana MET (SP44) RxDx Assay, emphasizing their first companion diagnostic designed to identify MET protein appearance in patients.
A report from the Drugs Technical Advisory Board's (DTAB) subcommittee, led by Dr. Nilima Kshirsagar, found 16 fixed dose combinations (FDCs) to be irrational and suggested that they be banned because they could endanger human health. The DTAB concur
The Rajasthan Government has started the revival of Rajasthan Drugs and Pharmaceuticals Limited (RDPL), a Central Public Sector Undertaking (CPSU) in the state. RDPL is owned by the Central Government, which owns 51 percent, and the Rajasthan Governm
Remidio Innovative Solutions Pvt. Ltd., a leader in ophthalmic technology, has announced that it has received approval from the State FDA, Karnataka (CDSCO), the regulatory authority for medical devices, for its Medios HI (Humanizing Intellige...
, CDSCO.jpg)
